CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-11 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −30,823 | $36.46 | $1.1M | 217,101 |
| 2023-05-11 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,177 | $37.19 | $44K | 215,924 |
| 2023-05-11 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −7,706 | $36.46 | $281K | 47,949 |
| 2023-05-11 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −294 | $37.19 | $11K | 47,655 |
| 2023-05-11 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −32,000 | 944,164 | ||
| 2023-05-10 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +34,593 | $0.91 | $31K | 108,080 |
| 2023-05-10 | Schlanger David J Executive Chairman | Sale 10b5-1 | −32,574 | $37.68 | $1.2M | 75,506 |
| 2023-05-10 | Schlanger David J Executive Chairman | Sale 10b5-1 | −2,019 | $38.43 | $78K | 73,487 |
| 2023-05-10 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −34,593 | 482,228 | ||
| 2023-05-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +32,000 | $3.95 | $126K | 247,924 |
| 2023-05-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −30,151 | $37.69 | $1.1M | 217,773 |
| 2023-05-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,849 | $38.48 | $71K | 215,924 |
| 2023-05-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −7,538 | $37.69 | $284K | 56,117 |
| 2023-05-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −462 | $38.48 | $18K | 55,655 |
| 2023-05-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −32,000 | 976,164 | ||
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,095 | $37.61 | $229K | 71,318 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,568 | $38.24 | $60K | 69,750 |
| 2023-05-09 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +100,000 | $0.91 | $91K | 173,487 |
| 2023-05-09 | Schlanger David J Executive Chairman | Sale 10b5-1 | −7,025 | $36.85 | $259K | 166,462 |
| 2023-05-09 | Schlanger David J Executive Chairman | Sale 10b5-1 | −73,485 | $37.61 | $2.8M | 92,977 |
Page 25 of 77 · 1,524 trades